To determine whatdose of medicineis needed to open the cervix adequately
Phase 3
- Conditions
- Health Condition 1: - Health Condition 2: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Registration Number
- CTRI/2020/08/027122
- Lead Sponsor
- Internal Fluid Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients requiring operative hysteroscopy for intrauterine cavitory pathologies based on transvaginal ultrasound.
Exclusion Criteria
1. Contraindications to hysteroscopy (i.e. pregnancy, cervical malignancy, recent or recurrent pelvic inflammatory disease, marked cervical stenosis, profuse uterine bleeding or recent uterine perforation etc.)
2. Any possible contraindications to use of prostaglandins (known sensitivity to prostaglandins, cardiovascular disease, renal failure, severe bronchial asthma, glaucoma etc.)
3. Previous cervical surgery
4. Presence of significant uterovaginal prolapse impairing vaginal administration.
5. Unmarried women where administration of vaginal misoprostol cannot be done.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method